Article

Interim impact evaluation of the hepatitis C virus elimination program in Georgia

2018-02-24

Abstract excerpt

<h4>Background and Aims</h4> Georgia has one of the highest hepatitis C virus (HCV) prevalence rates in the world, with >5% of the adult population (~150,000 people) chronically infected. In April 2015, the Georgian government, in collaboration with CDC and other partners, launched a national program to eliminate HCV through scaling up HCV treatment and prevention interventions, with the aim of achieving a 90% re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b066d455-b79c-51c1-8cb2-6ed08e8203b5
DOI: 10.1101/270579

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Interim impact evaluation of the hepatitis C virus elimination program in GeorgiaDOI 10.1101/270579Read

Cost and cost-effectiveness of alternative screening and diagnostic pathways for achieving hepatitis C elimination in the country of GeorgiaSemantic proximity Read

Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.Semantic proximity Read

High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis – real-world data of HCV elimination program in GeorgiaSemantic proximity Read

An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia's corrections system, December 2013 - April 2015.Semantic proximity Read

Risk factors and genotype distribution of hepatitis C virus in Georgia: A nationwide population-based survey.Semantic proximity Read

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.Semantic proximity Read

The changing burden of hepatitis C virus infection in the United States: model-based predictions.Semantic proximity Read

Hepatitis C virus elimination: So close, so far?Semantic proximity Read

Development and implementation of site-specific Hepatitis C Virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study, a prospective single-arm intervention trialSemantic proximity Read

Hepatitis C virus (HCV) seroprevalence, RNA detection, and genotype distribution across Florida, 2015-2018.Semantic proximity Read

Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment.Semantic proximity Read

Modelling the elimination of hepatitis C virus infection as a public health threatSemantic proximity Read